186 related articles for article (PubMed ID: 22617250)
1. C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expression.
Bhardwaj V; Zhan Y; Cortez MA; Ang KK; Molkentine D; Munshi A; Raju U; Komaki R; Heymach JV; Welsh J
J Thorac Oncol; 2012 Aug; 7(8):1211-7. PubMed ID: 22617250
[TBL] [Abstract][Full Text] [Related]
2. Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells.
Zeng J; Zhang H; Tan Y; Sun C; Liang Y; Yu J; Zou H
BMC Cancer; 2018 May; 18(1):611. PubMed ID: 29848294
[TBL] [Abstract][Full Text] [Related]
3. Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects.
Li B; Torossian A; Sun Y; Du R; Dicker AP; Lu B
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e525-31. PubMed ID: 22836051
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines.
Iwasa T; Okamoto I; Suzuki M; Nakahara T; Yamanaka K; Hatashita E; Yamada Y; Fukuoka M; Ono K; Nakagawa K
Clin Cancer Res; 2008 Oct; 14(20):6496-504. PubMed ID: 18927289
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation.
Zhang T; Cui GB; Zhang J; Zhang F; Zhou YA; Jiang T; Li XF
Oncol Rep; 2010 Dec; 24(6):1683-9. PubMed ID: 21042768
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non-Small Cell Lung Cancers In Vitro and In Vivo.
Tao Z; Le Blanc JM; Wang C; Zhan T; Zhuang H; Wang P; Yuan Z; Lu B
Clin Cancer Res; 2016 Jan; 22(1):122-33. PubMed ID: 26728409
[TBL] [Abstract][Full Text] [Related]
8. Sanyang Xuedai enhances the radiosensitivity of human non-small cell lung cancer cells via increasing iNOS/NO production.
Wang L; Xia Y; Chen T; Zeng Y; Li L; Hou Y; Li W; Liu Z
Biomed Pharmacother; 2018 Jun; 102():618-625. PubMed ID: 29602129
[TBL] [Abstract][Full Text] [Related]
9. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.
Toulany M; Kehlbach R; Florczak U; Sak A; Wang S; Chen J; Lobrich M; Rodemann HP
Mol Cancer Ther; 2008 Jul; 7(7):1772-81. PubMed ID: 18644989
[TBL] [Abstract][Full Text] [Related]
10. Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated.
Park SY; Kim YM; Pyo H
Mol Cancer; 2010 Aug; 9():222. PubMed ID: 20731837
[TBL] [Abstract][Full Text] [Related]
11. Targeting epidermal growth factor receptor-associated signaling pathways in non-small cell lung cancer cells: implication in radiation response.
Choi EJ; Ryu YK; Kim SY; Wu HG; Kim JS; Kim IH; Kim IA
Mol Cancer Res; 2010 Jul; 8(7):1027-36. PubMed ID: 20587532
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models.
Sun Y; Moretti L; Giacalone NJ; Schleicher S; Speirs CK; Carbone DP; Lu B
J Thorac Oncol; 2011 Apr; 6(4):699-706. PubMed ID: 21325979
[TBL] [Abstract][Full Text] [Related]
13. [Effection and mechanism of radiosensitivity of non-small cell lung cancer cell line H358 following gefitinib treatment].
Deng J; Zhuang L; Chen Y
Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):841-7. PubMed ID: 22104217
[TBL] [Abstract][Full Text] [Related]
14. C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe.
Oike T; Komachi M; Ogiwara H; Amornwichet N; Saitoh Y; Torikai K; Kubo N; Nakano T; Kohno T
Radiother Oncol; 2014 May; 111(2):222-7. PubMed ID: 24746574
[TBL] [Abstract][Full Text] [Related]
15. Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.
Kim KW; Moretti L; Mitchell LR; Jung DK; Lu B
Clin Cancer Res; 2009 Oct; 15(19):6096-105. PubMed ID: 19773376
[TBL] [Abstract][Full Text] [Related]
16. AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer.
Moretti L; Li B; Kim KW; Chen H; Lu B
J Thorac Oncol; 2010 May; 5(5):680-7. PubMed ID: 20354451
[TBL] [Abstract][Full Text] [Related]
17. The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells.
Welsh JW; Mahadevan D; Ellsworth R; Cooke L; Bearss D; Stea B
Radiat Oncol; 2009 Dec; 4():69. PubMed ID: 20028557
[TBL] [Abstract][Full Text] [Related]
18. Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities.
Riaz MA; Sak A; Erol YB; Groneberg M; Thomale J; Stuschke M
Sci Rep; 2019 Feb; 9(1):1282. PubMed ID: 30718758
[TBL] [Abstract][Full Text] [Related]
19. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study.
Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239
[TBL] [Abstract][Full Text] [Related]
20. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells.
Raghavan P; Tumati V; Yu L; Chan N; Tomimatsu N; Burma S; Bristow RG; Saha D
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e507-14. PubMed ID: 22795803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]